AACR logo

More articles from Chemical Therapeutics

MPT0B098, a Novel Microtubule Inhibitor That Destabilizes the Hypoxia-Inducible Factor-1α mRNA through Decreasing Nuclear–Cytoplasmic Translocation of RNA-Binding Protein HuR
Yun-Ching Cheng, Jing-Ping Liou, Ching-Chuan Kuo, Wen-Yang Lai, Kuang-Hsing Shih, Chi-Yen Chang, Wen-Yu Pan, Joseph T. Tseng, Jang-Yang Chang

Molecular Cancer Therapeutics Jul 2013, 12 (7) 1202-1212; DOI: 10.1158/1535-7163.MCT-12-0778
PG545, an Angiogenesis and Heparanase Inhibitor, Reduces Primary Tumor Growth and Metastasis in Experimental Pancreatic Cancer
Katherine T. Ostapoff, Niranjan Awasthi, Bercin Kutluk Cenik, Stefan Hinz, Keith Dredge, Roderich E. Schwarz, Rolf A. Brekken

Molecular Cancer Therapeutics Jul 2013, 12 (7) 1190-1201; DOI: 10.1158/1535-7163.MCT-12-1123
CRM1 and BRAF Inhibition Synergize and Induce Tumor Regression in BRAF-Mutant Melanoma
Roberto A. Salas Fragomeni, Hye Won Chung, Yosef Landesman, William Senapedis, Jean-Richard Saint-Martin, Hensin Tsao, Keith T. Flaherty, Sharon Shacham, Michael Kauffman, James C. Cusack

Molecular Cancer Therapeutics Jul 2013, 12 (7) 1171-1179; DOI: 10.1158/1535-7163.MCT-12-1171
Identification and Characterization of a Small-Molecule Inhibitor of Wnt Signaling in Glioblastoma Cells
Alessandra De Robertis, Silvia Valensin, Marco Rossi, Patrizia Tunici, Margherita Verani, Antonella De Rosa, Cinzia Giordano, Maurizio Varrone, Arianna Nencini, Carmela Pratelli, Tiziana Benicchi, Annette Bakker, Jeffrey Hill, Kanda Sangthongpitag, Vishal Pendharkar, Boping Liu, Fui Mee Ng, Siew Wen Then, Shi Jing Tai, Seong-Moon Cheong, Xi He, Andrea Caricasole, Massimiliano Salerno

Molecular Cancer Therapeutics Jul 2013, 12 (7) 1180-1189; DOI: 10.1158/1535-7163.MCT-12-1176-T
CXCR4-Targeted Therapy Inhibits VEGF Expression and Chondrosarcoma Angiogenesis and Metastasis
Xiaojuan Sun, Cherie Charbonneau, Lei Wei, Wentian Yang, Qian Chen, Richard M. Terek

Molecular Cancer Therapeutics Jul 2013, 12 (7) 1163-1170; DOI: 10.1158/1535-7163.MCT-12-1092
RAD51C-Deficient Cancer Cells Are Highly Sensitive to the PARP Inhibitor Olaparib
Ahrum Min, Seock-Ah Im, Young-Kwang Yoon, Sang-Hyun Song, Hyun-Jin Nam, Hyung-Seok Hur, Hwang-Phill Kim, Kyung-Hun Lee, Sae-Won Han, Do-Youn Oh, Tae-You Kim, Mark J. O'Connor, Woo-Ho Kim, Yung-Jue Bang

Molecular Cancer Therapeutics Jun 2013, 12 (6) 865-877; DOI: 10.1158/1535-7163.MCT-12-0950
Inhibition of Wee1, AKT, and CDK4 Underlies the Efficacy of the HSP90 Inhibitor XL888 in an In Vivo Model of NRAS-Mutant Melanoma
H. Eirik Haarberg, Kim H.T. Paraiso, Elizabeth Wood, Vito W. Rebecca, Vernon K. Sondak, John M. Koomen, Keiran S.M. Smalley

Molecular Cancer Therapeutics Jun 2013, 12 (6) 901-912; DOI: 10.1158/1535-7163.MCT-12-1003
Discovery of the Novel mTOR Inhibitor and Its Antitumor Activities In Vitro and In Vivo
Hua Xie, Mee-Hyun Lee, Feng Zhu, Kanamata Reddy, Zunnan Huang, Dong Joon Kim, Yan Li, Cong Peng, Do Young Lim, Soouk Kang, Sung Keun Jung, Xiang Li, Haitao Li, Weiya Ma, Ronald A. Lubet, Jian Ding, Ann M. Bode, Zigang Dong

Molecular Cancer Therapeutics Jun 2013, 12 (6) 950-958; DOI: 10.1158/1535-7163.MCT-12-1241
A Novel Inhibitor of c-Met and VEGF Receptor Tyrosine Kinases with a Broad Spectrum of In Vivo Antitumor Activities
Yoshiko Awazu, Kazuhide Nakamura, Akio Mizutani, Yuichi Kakoi, Hidehisa Iwata, Seiji Yamasaki, Naoki Miyamoto, Shinichi Imamura, Hiroshi Miki, Akira Hori

Molecular Cancer Therapeutics Jun 2013, 12 (6) 913-924; DOI: 10.1158/1535-7163.MCT-12-1011
Preclinical Evaluation of a Novel ATM Inhibitor, KU59403, In Vitro and In Vivo in p53 Functional and Dysfunctional Models of Human Cancer
Michael A. Batey, Yan Zhao, Suzanne Kyle, Caroline Richardson, Andrew Slade, Niall M.B. Martin, Alan Lau, David R. Newell, Nicola J. Curtin

Molecular Cancer Therapeutics Jun 2013, 12 (6) 959-967; DOI: 10.1158/1535-7163.MCT-12-0707

Main menu

User menu

Search

More articles from Chemical Therapeutics

Pages

Articles

Info for

About MCT